Advancing Emergency Department-initiated Buprenorphine

Overview

Journal J Am Coll Emerg Physicians Open

Publisher Elsevier

Specialty Emergency Medicine

Date 2021 Jun 28

PMID 34179878

Citations 6

Authors

Kristen Huntley

Emily Einstein

Terri Postma

Anita Thomas

Shari Ling

Wilson Compton

Affiliations

Soon will be listed here.

Abstract

Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid-related overdoses during the COVID-19 public health emergency. Many emergency departments (EDs) across the country are implementing ED-initiated buprenorphine programs, and this is a method to address and prevent opioid overdoses. Resources are available to overcome barriers and take action.

Citing Articles

Impact of COVID-19 Pandemic on Emergency Department Visits for Opioid Use Disorder Across University of California Health Centers.

Heshmatipour M, Ng D, Yi-Wen Truong E, Zheng J, Chan A, Wang Y West J Emerg Med. 2024; 25(6):883-889.

PMID: 39625758 PMC: 11610740. DOI: 10.5811/westjem.18468.

Association Between Emergency Department Operational Metrics and Substance Use Disorder Treatment Interest in Two Rhode Island Hospitals.

Arbaugh S, Chambers L, Gaither R, Hallowell B, Daly M, Marshall B R I Med J (2013). 2024; 107(7):22-27.

PMID: 38917311 PMC: 11476007.

Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs.

Sue K, Chawarski M, Curry L, McNeil R, Coupet Jr E, Schwartz R JAMA Netw Open. 2023; 6(5):e2312718.

PMID: 37163263 PMC: 10173026. DOI: 10.1001/jamanetworkopen.2023.12718.

Resident attitudes, experiences, and preferences on initiating buprenorphine in the emergency department: A national survey.

Yu M, Hawk K AEM Educ Train. 2022; 6(3):e10779.

PMID: 35784380 PMC: 9242423. DOI: 10.1002/aet2.10779.

Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder.

Hawk K, McCormack R, Edelman E, Coupet Jr E, Toledo N, Gauthier P JAMA Netw Open. 2022; 5(1):e2144955.

PMID: 35076700 PMC: 8790663. DOI: 10.1001/jamanetworkopen.2021.44955.

References

Melnick E, Jeffery M, Dziura J, Mao J, Hess E, Platts-Mills T . User-centred clinical decision support to implement emergency department-initiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomised EMBED trial. BMJ Open. 2019; 9(5):e028488. PMC: 6550013. DOI: 10.1136/bmjopen-2018-028488. View

DOnofrio G, Chawarski M, OConnor P, Pantalon M, Busch S, Owens P . Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention. J Gen Intern Med. 2017; 32(6):660-666. PMC: 5442013. DOI: 10.1007/s11606-017-3993-2. View

Rockwell K, Gilroy A . Incorporating telemedicine as part of COVID-19 outbreak response systems. Am J Manag Care. 2020; 26(4):147-148. DOI: 10.37765/ajmc.2020.42784. View

Samuels E, Clark S, Wunsch C, Jordison Keeler L, Reddy N, Vanjani R . Innovation During COVID-19: Improving Addiction Treatment Access. J Addict Med. 2020; 14(4):e8-e9. PMC: 7236851. DOI: 10.1097/ADM.0000000000000685. View

Williams A, Nunes E, Bisaga A, Levin F, Olfson M . Development of a Cascade of Care for responding to the opioid epidemic. Am J Drug Alcohol Abuse. 2019; 45(1):1-10. PMC: 6404749. DOI: 10.1080/00952990.2018.1546862. View

DOnofrio G, McCormack R, Hawk K . Emergency Departments - A 24/7/365 Option for Combating the Opioid Crisis. N Engl J Med. 2018; 379(26):2487-2490. DOI: 10.1056/NEJMp1811988. View

Weiss R, Rao V . The Prescription Opioid Addiction Treatment Study: What have we learned. Drug Alcohol Depend. 2017; 173 Suppl 1:S48-S54. PMC: 6866670. DOI: 10.1016/j.drugalcdep.2016.12.001. View

Huhn A, Hobelmann J, Strickland J, Oyler G, Bergeria C, Umbricht A . Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States. JAMA Netw Open. 2020; 3(2):e1920843. PMC: 8188643. DOI: 10.1001/jamanetworkopen.2019.20843. View

Morgan J, Schackman B, Weinstein Z, Walley A, Linas B . Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Drug Alcohol Depend. 2019; 200:34-39. PMC: 6613830. DOI: 10.1016/j.drugalcdep.2019.02.031. View

10.

Huntley K, Einstein E, Postma T, Thomas A, Ling S, Compton W . Advancing emergency department-initiated buprenorphine. J Am Coll Emerg Physicians Open. 2021; 2(3):e12451. PMC: 8208651. DOI: 10.1002/emp2.12451. View

11.

Samuels E, Dwyer K, Mello M, Baird J, Kellogg A, Bernstein E . Emergency Department-based Opioid Harm Reduction: Moving Physicians From Willing to Doing. Acad Emerg Med. 2016; 23(4):455-65. DOI: 10.1111/acem.12910. View

12.

Samuels E, DOnofrio G, Huntley K, Levin S, Schuur J, Bart G . A Quality Framework for Emergency Department Treatment of Opioid Use Disorder. Ann Emerg Med. 2018; 73(3):237-247. PMC: 6817947. DOI: 10.1016/j.annemergmed.2018.08.439. View

13.

Lowenstein M, Kilaru A, Perrone J, Hemmons J, Abdel-Rahman D, Meisel Z . Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey. Am J Emerg Med. 2019; 37(9):1787-1790. PMC: 7556325. DOI: 10.1016/j.ajem.2019.02.025. View

14.

DOnofrio G, Edelman E, Hawk K, Pantalon M, Chawarski M, Owens P . Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). Implement Sci. 2019; 14(1):48. PMC: 6505286. DOI: 10.1186/s13012-019-0891-5. View

15.

Ellison J, Walley A, Feldman J, Bernstein E, Mitchell P, Koppelman E . Identifying Patients for Overdose Prevention With ICD-9 Classification in the Emergency Department, Massachusetts, 2013-2014. Public Health Rep. 2017; 131(5):671-675. PMC: 5230809. DOI: 10.1177/0033354916661981. View

16.

Jennings L, Bogan C, McCauley J, Moreland A, Lane S, Ward R . Rates of substance use disorder treatment seeking visits after emergency department-initiated buprenorphine. Am J Emerg Med. 2020; 38(5):975-978. PMC: 7884203. DOI: 10.1016/j.ajem.2020.02.011. View

17.

Sahota P, Shastry S, Mukamel D, Murphy L, Yang N, Lotfipour S . Screening emergency department patients for opioid drug use: A qualitative systematic review. Addict Behav. 2018; 85:139-146. DOI: 10.1016/j.addbeh.2018.05.022. View

18.

Pashmineh Azar A, Cruz-Mullane A, Podd J, Lam W, Kaleem S, Lockard L . Rise and regional disparities in buprenorphine utilization in the United States. Pharmacoepidemiol Drug Saf. 2020; 29(6):708-715. DOI: 10.1002/pds.4984. View

19.

Wang Q, Kaelber D, Xu R, Volkow N . COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2020; 26(1):30-39. PMC: 7488216. DOI: 10.1038/s41380-020-00880-7. View

20.

Weiner S, Baker O, Bernson D, Schuur J . One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose. Ann Emerg Med. 2019; 75(1):13-17. PMC: 6920606. DOI: 10.1016/j.annemergmed.2019.04.020. View